Elevance Health, Inc. · NYSE:ELV
Elevance Health — Q2 2024 Earnings Presentation
13 slides from Elevance Health's earnings presentation, Jul 17, 2024
Slide 1: Elevance Health 2Q 2024 Earnings Presentation
Elevance Health 2Q 2024 Earnings Presentation July 17, 2024
Slide 2: Key Highlights
Key Highlights 1 2Q 2024 Results • • Elevance Health second quarter results reflect disciplined execution of our strategic initiatives during a dynamic time for the industry 2Q 2024 adjusted diluted EPS of $10.12 grew 12% year-over-year • 2Q 2024 adjusted operating gain of $2.8B grew 6% year-over-ye
Slide 3: Enterprise Results 2Q 2024
Enterprise Results 2Q 2024 Results Key Highlights Elevance Health 2Q 2024 2Q 2023 Change (%/bps/$) • Elevance Health second quarter results reflect focused execution of Operating Revenue1 $43.2B $43.4B (0.4%) our enterprise strategy in a dynamic operating environment Medical Loss Ratio 86.3% 86.4% (
Slide 4: Health Benefits 2Q 2024 Results
Health Benefits 2Q 2024 Results Key Highlights • Health Benefits demonstrated the resilience of our diversified mix of business in the quarter Health Benefits 2Q 2024 2Q 2023 Change (%/bps) • Operating revenue was impacted by declines in Medicaid membership, Operating Revenue1 $37.2B $38.0B (2.2%) p
Slide 5: Health Services 2Q 2024 Results
Health Services 2Q 2024 Results Key Highlights • Carelon delivered growth in services while scaling key value drivers Carelon 2Q 2024 2Q 2023 Change (%/bps) • Serves as the enterprise flywheel for growth, integrating physical, behavioral, social and pharmacy Operating Revenue1 $13.3B $12.1B 10.3% se
Slide 6: Flywheel Supports Our Long-Term Growth Algorithm
Flywheel Supports Our Long-Term Growth Algorithm Health Benefits Health Services Approximately 46M medical members Optimize Invest in Integrated portfolio of whole health balanced across commercial, the Core Growth solutions connecting care across Medicaid and Medicare, leveraging physical, behavior
Slide 7: Long-Term Growth Algorithm
Long-Term Growth Algorithm Targeting at least 12% average annual growth in Adjusted Diluted EPS Adjusted Operating Gain – Upper Single Digit to Low Double Digit CAGR1 Revenue Growth Upper Single Digit CAGR1 + Adjusted Operating Margin Expanding to 6.5% - 7.0% by 2027 + Capital Deployment Approximate
Slide 8: Committed to Strong Growth Over the Long-Term
Committed to Strong Growth Over the Long-Term Health Benefits Carelon4 Elevance Health Dividends Upper Single 20% Mid to Upper Digit CAGR2,3 Single Digit CAGR2,3 $156B $138B M&A/ Organic Mid Teens Reinvestment CAGR2,3 Capital 50% Revenue1 $41B Allocation (in Billions) 2022 2027 2022 2027 2022 2027 T
Slide 9: Forward-Looking Statements
Forward-Looking Statements This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words su
Slide 10: Non-GAAP Measures and Basis of Presentation
Non-GAAP Measures and Basis of Presentation This document references non-GAAP measures. These non-GAAP measures are intended to aid investors when comparing Elevance Health’s financial results among periods and are not intended to be alternatives to any measure calculated in accordance with GAAP. Re
Slide 11: GAAP Reconciliation — Shareholders' Net Income and EPS
Elevance Health GAAP Reconciliation — Shareholders’ Net Income and Shareholders’ Earnings Per Diluted Share Three Months Ended Jun 30 Six Months Ended Jun 30 (In millions, except per share data) 2024 2023 Change 2024 2023 Change Shareholders' net income $2,300 $1,853 24.1% $4,546 $3,842 18.3% Add /
Slide 12: GAAP Reconciliation — Operating Gain, Expense Ratio, 2024 Outlook
Elevance Health GAAP Reconciliation — Operating Gain, Operating Expense Ratio, and 2024 Outlook Three Months Ended Jun 30 Six Months Ended Jun 30 (In millions) 2024 2023 Change 2024 2023 Change Reportable segments operating gain $2,765 $2,628 5.2% $5,781 $5,459 5.9% Add / (Subtract): Transaction and
Slide 13: Elevance Health
nw Elevance Health